$QNTA #BreakingNews ! Medolife Rx, Inc. ("Medolife") (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of QNTA product, Escozine, as a COVID-19 treatment. https://finance.yahoo.com/news/medolife-rx-submits-final-clinical-130000052.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.